Understanding the interactions between diabetes and heart disease

Program Overview

According to published statistics, heart disease and stroke are the leading causes of hospitalization. Furthermore, one third of all men and women in Canada die from cardiovascular disease (CVD). It is therefore one of the most important disease areas and clinical challenges for family physicians to effectively manage.  Cardiovascular disease is also the leading cause of morbidity and mortality in those living with diabetes and consequently the overlap between diabetes care and cardiovascular outcomes is of utmost importance in contemporary clinical practice.

The Peter Munk Cardiac Centre and the Banting and Best Diabetes Centre are leaders in research and clinical care of cardiovascular disease and diabetes within the University Health Network in Toronto. Areas of expertise include: innovative cellular research and its translation for improved clinical outcomes; collaborations in enhancing patient care with our local community partners; combining evidence-based diabetes therapies; and advanced techniques in diagnostic imaging, cardiovascular intervention, and surgery. Via these areas of expertise, the Peter Munk Cardiac Centre and the Banting and Best Diabetes Centre are striving to transform the landscape of cardiovascular and diabetes care. The Inaugural Joint Cardiovascular-Diabetes Symposium represents a novel partnership that will continue to advance this area.

The integrative team philosophy of the Peter Munk Cardiac Centre and the Banting and Best Diabetes Centre extends to the critical clinical and communication links with our community partners, especially family physicians, who entrust us with the care of their patients. With this symposium, we aim to strengthen those clinical and communication links, enhancing the continuum of care from hospital to community.

Learning Objectives

The overall aim of this symposium is to highlight optimal assessment and management of patients at risk for the complications of CVD and diabetes, through discussion of the latest thinking and best practices for office-based patient assessment with emphasis on an integrative patient-focused approach.

After attending this symposium, you will be better able to:

  • Summarize latest evidence on cardiovascular risk reduction in diabetes and integrate latest recommendations into clinical practice
  • Discuss management of patients with both heart failure and diabetes, using evidence-based therapies in combination
  • Critically assess the benefits of using SGLT2 inhibitors and GLP1 analogues to treat diabetes and gain competency safely prescribing these medications in clinical practice
  • Interpret some of the challenges patients experience achieving and sustaining meaningful weight loss to enhance effective counsel on dietary therapy
  • Describe latest clinical practice guidelines for treating hypertension and dyslipidemia in diabetes and the relationship between heart failure and diabetes
  • Identify the positive impact of exercise therapy in treating diabetes and integrate new and effective approaches to motivate patients
  • Demonstrate informed anticoagulation choices when treating atrial fibrillation and atherosclerosis
  • Develop an approach to specific clinical scenarios when assessing and treating patients with adult congenital heart disease, such as heart failure and pregnancy
  • Evaluate contemporary percutaneous procedures for valvular heart disease, including management of aortic stenosis and mitral regurgitation with TAVR and Mitraclip
  • Review assessment and management of aortic disease, particularly acute aortic syndromes

Target Audience

  • Family Physicians
  • Cardiologists
  • Endocrinologists
  • Radiologists
  • Internists
  • Nurses and Allied Health professionals involved in cardiovascular patient care